Search Results - "Shulzhenko, L. V."

Severe bronchial asthma patient care organization in various regions of the Russian Federation. From endotypes and phenotypes of bronchial asthma to personalized choice of therapy by Avdeev, S. N., Volkova, O. A., Demko, I. V., Ignatova, G. L., Leshchenko, I. V., Kanukova, N. A., Kudelya, L. M., Nevzorova, V. A., Nedashkovskaya, N. G., Ukhanova, O. P., Shulzhenko, L. V., Fassakhov, R. S.

“…The meeting of the Expert board was held in Moscow on June 24, 2019, at which the following issues were considered: the applicability of a new terminology…”
Get full text

Speckle-Tracking Echocardiography in Assessment of Breast Cancer Therapy-Related Subclinical Cardiac Dysfunction by Akbalaeva, B. A., Shulzhenko, L. V., Pershukov, I. V., Raiimbek uulu, N., Batyraliev, T. A., Gurovich, O. V., Vinogradskaia, V. V., Jainakbayev, N. T., Seidalin, A. O., Kamaliyeva, M. R.

“…Background : Cancer therapy-related cardiac dysfunction (CTRCD) is a new term that encompasses a wide range of potential manifestations and is etiologically…”
Get full text

Increased treatment adherence in patients with chronic obstructive pulmonary disease when using a fixed triple combination by Bolotova, E. V., Dudnikova, A. V., Shulzhenko, L. V.

“…Introduction. Poor medication adherence significantly increases the likelihood of complications, which leads to a decrease in quality of life (QoL) in patients…”
Get full text

Echo-loop of subclinical cardiovascular toxicity in women associated with HER2-positive breast cancer therapy by Pershukov, I. V., Akbalaeva, B. A., Shulzhenko, L. V., Batyraliev, T. A., Gurovich, O. V., Vinogradskaia, V. V., Karben, Z. A., Fettser, D. V., Kuznetsova, T. N., Ivanenkova, E. Yu, Raiimbek uulu, N., Kvasova, M. V., Kalmatov, R. K., Imetova, Ja. B., Mamatova, S. M., Jainakbayev, N. T., Seidalin, A. O., Rakhalskaya, N. N.

“…Aim . To assess the incidence and timing of subclinical cardiac dysfunction associated with therapy for HER2-positive locally advanced or metastatic breast…”
Get full text

The Clinical Evolution of Diffuse Myocardial Fibrosis in Patients With Arterial Hypertension and Heart Failure With Mildly Reduced Ejection Fraction Treated by Olmesartan or Sacubitril / Valsartan by Shulzhenko, L V, Pershukov, I V, Batyraliev, T A, Karben, Z A, Gurovich, O V, Fettser, D V, Kuznetsova, T N, Ivanenkova, E Yu, Akbalaeva, B A, Rayimbek Uulu N, N, Toygonbaev, S, Mansharipova, A T, Seidalin, A O, Zyablova, E I, Kalmatov, R K, Imetova, Zh B, Vinogradskaia, V V, Gaydukova, E V

“…Aim      A 12-month evaluation of the potentialities of the angiotensin II receptor inhibitor olmesartan (Olme) and the angiotensin receptor and neprilysin…”
Get more information

Myocardial Revascularization in Patients With Chronic Ischemic Heart Disease Combined With Chronic Obstructive Pulmonary Disease by Zafiraki, V K, Skaletsky, K V, Kosmacheva, E D, Shulzhenko, L V, Ramazanov, J M, Omarov, A A

“…Currently enough data has been accumulated to consider chronic obstructive pulmonary disease (COPD) as one of important factors of poor prognosis in patients…”
Get more information

Changing Clinical Presentation of Acute Coronary Syndrome in Patients With Chronic Obstructive Pulmonary Disease by Zafiraki, V K, Namitokov, A M, Kosmacheva, E D, Shulzhenko, L V, Omarov, A A, Ramazanov, J M, Pershukov, I V

“…to determine clinical features of acute coronary syndrome (ACS) in patients with chronic obstructive pulmonary disease (COPD). We included into this study 272…”
Get more information

The role of reduction of glomerular filtration rate in outcomes of drug-eluting stents implantation in patients with ischemic heart disease and chronic kidney disease by Shul'zhenko, L V, Pershukov, I V, Batyraliev, T A, Fettser, D V, Sidorenko, B A

“…Patients (n=432) subjected to percutaneous coronary interventions (PCI) with implantation of one or more drug eluting stents (DES) in 2005 were included in…”
Get more information

In-hospital and long-term (to 3 years) results of using bare-metal stents in patients with coronary artery disease and chronic kidney disease by Shul'zhenko, L V, Batyraliev, T A, Pershukov, I V, Fettser, D V, Sidorenko, B A

“…Patients (n=727) who had been subjected to implantation of one or several standard stents in 2004 were included into this study. These patients were divided…”
Get more information

Experience of using omalizumab in patients with severe bronchial asthma by Bolotova, E. V., Dudnikova, A. V., Shulzhenko, L. V.

“…Introduction. New insights into the complex pathophysiology of severe asthma (SA) have led to the development of personalized treatment strategies using…”
Get full text

Experience of using a triple fixed combination in the treatment of patients with chronic obstructive pulmonary disease by Bolotova, Elena V., Dudnikova, Anna V., Shulzhenko, Larisa V.

“…Aim. To evaluate the effectiveness of a fixed triple combination of vilanterol/umeclidinium bromide/fluticasone furoate in the treatment of chronic obstructive…”
Get full text

Current treatment methods for invasive candidiasis in donor organ recipients (part I) by E. V. Bolotova, L. V. Shulzhenko, V. A. Porhanov, A. E. Antinyan, O. V. Bozhko, A. A. Smolin

“…In donor organ recipients development of invasive fungous infections, the majority of which is caused by Candida spp and Aspergillus spp, significantly…”
Get full text

MODERN APPROACH TO INVASIVE CANDIDIASIS DIAGNOSIS AND TREATMENT IN DONOR ORGAN RECIPIENTS (PART II) by E. V. Bolotova, L. V. Shulzhenko, V. A. Porhanov, A. E. Antinyan, O. V. Bozhko, A. A. Smolin

“…In donor organ recipients we observe sufficiently high risk of invasive mycotic infection development and most of them are caused by Candida spp and…”
Get full text

Current treatment methods for invasive candidiasis in donor organ recipients (part I) by E. V. Bolotova, L. V. Shulzhenko, V. A. Porhanov, A. E. Antinyan, O. V. Bozhko, A. A. Smolin

“…In donor organ recipients development of invasive fungous infections, the majority of which is caused by Candida spp and Aspergillus spp, significantly…”
Get full text

MODERN APPROACH TO INVASIVE CANDIDIASIS DIAGNOSIS AND TREATMENT IN DONOR ORGAN RECIPIENTS (PART II) by E. V. Bolotova, L. V. Shulzhenko, V. A. Porhanov, A. E. Antinyan, O. V. Bozhko, A. A. Smolin

“…In donor organ recipients we observe sufficiently high risk of invasive mycotic infection development and most of them are caused by Candida spp and…”
Get full text

Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board by Avdeev, Sergey N., Emelyanov, Alexander V., Aisanov, Zaurbek R., Sinopalnikov, Alexander I., Fomina, Daria S., Nenasheva, Natalia M., Leshchenko, Igor V., Zaikova-Khelimskaia, Irina V., Vizel, Alexander A., Demko, Irina V., Shaporova, Nataliia L., Shulzhenko, Larisa V., Shabanov, Evgeny A.

“…Asthma and chronic obstructive pulmonary disease remain major problems of medicine, and still there is need to improve the level and quality of diagnosis of…”
Get full text

The first case of Cesarean section in a pregnant woman during extracorporeal membrane oxygenation (ECMO) in Russia by Skopets, Alexander A., Zharov, A. S., Potapov, S. I., Afonin, E. S., Andreeva, M. D., Galdina, T. V., Shulzhenko, L. V., Bezukh, E. V., Porhanov, V. A.

“…A 22-year-old pregnant woman (34.6 weeks of pregnancy) with A(H1N1) influenza-associated acute respiratory distress syndrome was admitted to the intensive care…”
Get full text

CHARACTERISTICS OF THE GINGIVAL AND LARGE SALIVARY GLANDS MAST CELLS OF THE HUMAN BEING DURING DEPLOYMENT OF THE 11-YEAR SOLAR CYCLE by O. A. Pavlovskaya, L. V. Shulzhenko

“…Study of gum disease and salivary glands often involves the study of mast cells, which are known to belong to a group of cellular factors innate immunity. The…”
Get full text

Multicenter retrospective analysis of the patients with sarcoidosis with a 10 year interval in observations by Vizel', I Iu, Shmelev, E I, Baranova, O P, Barlamov, P N, Borodina, G L, Denisova, O A, Dobin, V L, Kulbaisov, A M, Kupaev, V I, Listopadova, M V, Ovsiannikov, N V, Os'kin, D N, Petrov, D V, Solov'ev, K I, Shul'zhenko, L V, Vizel', A A

“…Comparison of the state of 83 patients with histologically confirmed sarcoidosis observed with a 10 year interval revealed remission in 47% of the cases. The…”
Get more information

Efficacy and safety of enoxaparin use during drug-eluting stents implantation by Mustafaoglu, F, Petrakova, L N, Pershukov, I V, Batyraliev, T A, Pia, Iu V, Lazarev, I A, Ramazanov, D M, Shul'zhenko, L V, Kadyrov, B K, Sal'nikov, D V, Dolgikh, N N, Sidorenko, B A

“…We assessed possibility of the use of low molecular heparin enoxaparin during percutaneous coronary interventions (PCI) with implantation of drug eluting…”
Get more information